Nos publications
Mise à jour novembre 2023
Pagination
- Page précédente
- Page 7
- Page suivante
Title | Authors | Year | Journal | Link to Article | Intended Audience Trier par ordre croissant | Purpose |
---|---|---|---|---|---|---|
Pratiques à suivre en matière de sérologie: Anti-M | Clarke G, Cote J, Lane D | 2017 | Blood.ca website | View Pratiques à suivre en matière de sérologie: Anti-M | Health care providers | Benchmarking and standard setting |
Regenerative Therapy and Immune Modulation Using Umbilical Cord Blood-Derived Cells | Damien P, Allan DS | 2015 | Biol Blood Marrow Transplant | View Regenerative Therapy and Immune Modulation Using Umbilical Cord Blood-Derived Cells | Health care providers | Other |
Switching to extended half-life products in Canada - preliminary data | Keepanasseril A, Stoffman J, Bouskill V, Carcao M, Iorio A, Jackson S | 2017 | Haemophilia | View Switching to extended half-life products in Canada - preliminary data | Health care providers | Clinical research |
The entity of immunoglobulin A-related anaphylactic transfusion reactions is not evidence based | Sandler SG, Eder AF, Goldman M, Winters JL | 2015 | Transfusion | View The entity of immunoglobulin A-related anaphylactic transfusion reactions is not evidence based | Health care providers | Clinical research |
The rationale for platelet transfusion during cardiopulmonary bypass: an observational study | Zaffar N, Joseph A, Mazer CD, Nisenbaum R, Karkouti K, Tinmouth A, Peterson MD, Pavenski K, Callum J, Cserti-Gazdewich C, Shehata N | 2013 | Can J Anaesth | View The rationale for platelet transfusion during cardiopulmonary bypass: an observational study | Health care providers | Clinical research |
Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection | Greco-Stewart V, Kiernan J, Killeen D, Haun S, Mercer D, Young K, Liwski RS, Allan DS | 2018 | Transfusion | View Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection | Health care providers | Clinical research |
Immune Globulin Products | Harding R, Lazarus A | 2018 | Clinical Guide to Transfusion | View Immune Globulin Products | Health care providers | Other |
Improving quality of care for patients with iron deficiency anemia presenting to the emergency department | Khadadah F, Callum J, Shelton D, Lin Y | 2018 | Transfusion | View Improving quality of care for patients with iron deficiency anemia presenting to the emergency department | Health care providers | Clinical research |
Acellular pertussis vaccine effectiveness and waning immunity in Alberta, Canada: 2010–2015, a Canadian Immunization Research Network (CIRN) study | Bell CA, Russell ML, Drews SJ, Simmonds KA, Svenson LW, Schwartz KL, Kwong JC, Mahmud SM, Crowcroft NS | 2019 | Vaccine | View Acellular pertussis vaccine effectiveness and waning immunity in Alberta, Canada: 2010–2015, a Canadian Immunization Research Network (CIRN) study | Health care providers | Clinical research |
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review | Warkentin TE | 2019 | Expert Rev Hematol | View High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review | Health care providers | Clinical research |
Striking the balance: protecting data privacy in research | Ward R | 2019 | Blood.ca website | View Striking the balance: protecting data privacy in research | Health care providers | Other |
Acquired coagulation disorders | Warkentin T | 2020 | Oxford Textbook of Medicine, 6th edn | View Acquired coagulation disorders | Health care providers | Benchmarking and standard setting |
Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty | Hwang SR, Wang Y, Weil EL, Padmanabhan A, Warkentin TE, Pruthi RK | 2020 | Platelets | View Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty | Health care providers | Clinical research |
COVID-19 convalescent plasma: Interim recommendations from the AABB | Cohn CS, Estcourt L, Grossman BJ, Pagano MB, Allen ES, Bloch EM, Casadevall A, Devine DV, Dunbar NM, Foroutan F, Gniadek TJ, Goel R, Gorlin J, Joyner MJ, Metcalf RA, Raval JS, Rice TW, Shaz BH, Vassallo RR, Winters JL, Beaudoin G, Tobian AAR | 2021 | Transfusion | View COVID-19 convalescent plasma: Interim recommendations from the AABB | Health care providers | Clinical research |
Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review | Leblanc J-F, Germain M, Delage G, O'Brien S, Drews SJ, Lewin A | 2020 | Transfusion | View Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review | Health care providers | Clinical research |
Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders | Olasupo OO, Haddix C, Nakar C, Maahs J, Greist A, Ghafoor A, Donfield SM, Iorio A, Shapiro AD | 2022 | Eur J Haematol | View Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders | Health care providers | Benchmarking and standard setting |
Concentré de recherche: Saignement pendant la chirurgie cardiaque?: le?concentré de complexe prothrombique est-il une solution de rechange au plasma? | Kron A | 2021 | Blood.ca website | View Concentré de recherche: Saignement pendant la chirurgie cardiaque?: le?concentré de complexe prothrombique est-il une solution de rechange au plasma? | Health care providers | Clinical research |
Transfusion thresholds in myelodysplastic syndrome - Helping patients live better | Balitsky A, Arnold D | 2022 | Transfusion | View Transfusion thresholds in myelodysplastic syndrome - Helping patients live better | Health care providers | Clinical research |
A cross-sectional study of haemolytic disease of the newborn in Uganda | Dhabangi A, Nankunda J, Okaba V, Nakubulwa S, Hume HA, Dzik WH, Heddle NM | 2022 | Vox Sang | View A cross-sectional study of haemolytic disease of the newborn in Uganda | Health care providers | Clinical research |
Auditing a recently implemented massive hemorrhage protocol: feasibility of assessing pre-specified metrics and compliance | Leis M, Clarfield L, Lin Y, Gupta A, Da Luz L | 2023 | CJEM | View Auditing a recently implemented massive hemorrhage protocol: feasibility of assessing pre-specified metrics and compliance | Health care providers | Benchmarking and standard setting |
KEL1 negative red cell transfusions for females of current or future child-bearing potential: A clinical impact and feasibility study | Ning S, Morin PA, Elahie A, Li N, Liu Y, Barty R, Clarke G, Zeller M, Heddle NM | 2023 | Transfusion | View KEL1 negative red cell transfusions for females of current or future child-bearing potential: A clinical impact and feasibility study | Health care providers | Clinical research |
A new diagnosis of Addison's disease with a twist | Alhabib M, McAssey K, Parker MJ | 2016 | J Endocrinol Diabetes | View A new diagnosis of Addison's disease with a twist | Health care providers | Clinical research |
An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients | Lieberman L, Liu Y, Portwine C, Barty RL, Heddle NM | 2014 | Transfusion | View An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients | Health care providers | Clinical research |
Blood and clots quizlet 1: Oral contraceptives and pulmonary embolism | Tseng E, Yeh C, Shih A, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 1: Oral contraceptives and pulmonary embolism | Health care providers | Benchmarking and standard setting |
Coagulation factor concentrates | Poon MC | 2016 | Clinical Guide to Transfusion | View Coagulation factor concentrates | Health care providers | Other |
Donor selection for recipient safety | Goldman M | 2013 | ISBT Sci Ser | View Donor selection for recipient safety | Health care providers | Clinical research |
Exploring donor and product factors and their impact on red cell post-transfusion outcomes | Ning S, Heddle NM, Acker JP | 2018 | Transfus Med Rev | View Exploring donor and product factors and their impact on red cell post-transfusion outcomes | Health care providers | Clinical research |
Fondaparinux for treatment of heparin-induced thrombocytopenia: too good to be true? | Warkentin TE | 2017 | J Am Coll Cardiol | View Fondaparinux for treatment of heparin-induced thrombocytopenia: too good to be true? | Health care providers | Clinical research |
Impact de la grippe pandémique A (H1N1) sur les services de laboratoire | Patel SN, Gubbay JB, Bastien N, Booth T, Charest H, Chernesky M, Couillard M, Drews S, Garceau R, Gubbay J, Guercio S, Fearon M, Fonseca K, Hatchette T, Horsman G, Larke B, Li Y, Majury A, Ouellette O, Petric M, Ratnam S, Sevenhuysen C, Van Caeseele P | 2012 | Centre de collaboration nationale des maladies infectieuses: Examen des Preuves La grippe pandemique A (H1N1) | View Impact de la grippe pandémique A (H1N1) sur les services de laboratoire | Health care providers | Other |
L'étude ABLE : un essai clinique randomisé sur l'effet de la durée d'entreposage des concentrés érythrocytaires transfusés en réanimation | Lacroix J, Hébert PC, Fergusson D, Tinmouth A, Capellier G, Tiberghien P, Bardiaux L | 2015 | Transfus Clin Biol | View L'étude ABLE : un essai clinique randomisé sur l'effet de la durée d'entreposage des concentrés érythrocytaires transfusés en réanimation | Health care providers | Clinical research |
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura | Bhagirath VC, Kelton JG, Moore J, Arnold DM | 2012 | Transfusion | View Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura | Health care providers | Clinical research |
The impact of prolonged storage of red blood cells on cancer survival | Kekre N, Mallick R, Allan D, Tinmouth A, Tay J | 2013 | PLoS One | View The impact of prolonged storage of red blood cells on cancer survival | Health care providers | Clinical research |
The unique immunological features of heparin-induced thrombocytopenia | Staibano P, Arnold DM, Bowdish DM, Nazy I | 2017 | Br J Haematol | View The unique immunological features of heparin-induced thrombocytopenia | Health care providers | Basic research |
Hemolytic Disease of the Fetus and Newborn and Perinatal Immune Thrombocytopenia | Clarke G, Hannon J | 2018 | Clinical Guide to Transfusion | View Hemolytic Disease of the Fetus and Newborn and Perinatal Immune Thrombocytopenia | Health care providers | Other |
Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study | Jackson Chornenki NL, James TE, Barty R, Liu Y, Rochwerg B, Heddle NM, Siegal DM | 2020 | Transfusion | View Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study | Health care providers | Clinical research |
Donor selection, donor testing and pathogen reduction | Goldman M, Drews S, Devine D | 2019 | Clinical Guide to Transfusion | View Donor selection, donor testing and pathogen reduction | Health care providers | Benchmarking and standard setting |
Système Rhésus : l’anticorps anti-Cw | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Rhésus : l’anticorps anti-Cw | Health care providers | Benchmarking and standard setting |
Approach to red blood cell antibody testing during pregnancy: Answers to commonly asked questions | Minuk L, Clarke G, Lieberman L | 2020 | Can Fam Physician | View Approach to red blood cell antibody testing during pregnancy: Answers to commonly asked questions | Health care providers | Clinical research |
Circular of information for the use of human blood components: Red blood cells, leukocytes reduced (LR) | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Determining Optimal Treatment to Correct Preoperative Anemia and Reduce Perioperative Allogeneic Blood Transfusions in Cardiac Surgery: A Retrospective Cohort Study | Peel JK, Trudeau J, Tano R, Jadunandan S, Callum J, Moussa F, Lin Y | 2021 | J Cardiothorac Vasc Anesth | View Determining Optimal Treatment to Correct Preoperative Anemia and Reduce Perioperative Allogeneic Blood Transfusions in Cardiac Surgery: A Retrospective Cohort Study | Health care providers | Clinical research |
Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome | Kjeldsen-Kragh J, Fergusson DA, Kjaer M, Lieberman L, Greinacher A, Murphy MF, Bussel J, Bakchoul T, Corke S, Bertrand G, Oepkes D, Baker JM, Hume H, Massey E, Kaplan C, Arnold DM, Baidya S, Ryan G, Savoia HF, Landry D, Shehata N | 2020 | Blood Adv | View Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome | Health care providers | Clinical research |
L’exploration des frontières de l’hémolyse associée aux IgIV | Pendergrast J, Branch D | 2020 | Blood.ca website | View L’exploration des frontières de l’hémolyse associée aux IgIV | Health care providers | Benchmarking and standard setting |
Pre-transfusion Testing | Duncan J | 2020 | Clinical Guide to Transfusion | View Pre-transfusion Testing | Health care providers | Benchmarking and standard setting |
International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis | van Ommen CH, Albisetti M, Bhatt M, Bonduel M, Branchford B, Chalmers E, Chan A, Goldenberg NA, Holzhauer S, Monagle P, Nowak-Göttl U, Revel-Vilk S, Sciuccatie G, Sirachainan N, Male C | 2021 | J Thromb Haemost | View International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis | Health care providers | Benchmarking and standard setting |
Concentré de recherche: Le plasma de convalescents est un traitement inefficace pour les patients atteints de la COVID19 | Modi D | 2021 | Blood.ca website | View Concentré de recherche: Le plasma de convalescents est un traitement inefficace pour les patients atteints de la COVID19 | Health care providers | Clinical research |
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F | 2022 | Blood Adv | View Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Health care providers | Clinical research |
Plaquettes extraites de la couche leucoplaquettaire à teneur réduite en agents pathogènes | Blais-Normandin I, Tordon B, Anani W | 2022 | Blood.ca website | View Plaquettes extraites de la couche leucoplaquettaire à teneur réduite en agents pathogènes | Health care providers | Benchmarking and standard setting |
Management of immune‐mediated thrombocytopenia | Gabe C, Arnold D, Smith J, T W | 2022 | Rossi's Principles of Transfusion Medicine | View Management of immune‐mediated thrombocytopenia | Health care providers | Benchmarking and standard setting |
Why We Swab: A library of stories in stem cell donation | Jagelaviciute G, Kum E, Li EW, Rosenfeld A, Williams K, Kandel R, DeGurse N, Park B, Okonofua S, Sano L, Gerofsky M, Sharp A, Hatkar R, Thyagu S, Fingrut WB | 2022 | Transfusion | View Why We Swab: A library of stories in stem cell donation | Health care providers | Ethical, legal & social implications research |
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Lin Y-CJ, Evans DH, Robbins NF, Orjuela G, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras A-C, Tuite A, Yi Q-L, O’Brien SF, Drews SJ | 2022 | Microbiol Spectr | View Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Health care providers | Benchmarking and standard setting |